These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38791570)

  • 21. Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis.
    Toedter G; Li K; Marano C; Ma K; Sague S; Huang CC; Song XY; Rutgeerts P; Baribaud F
    Am J Gastroenterol; 2011 Jul; 106(7):1272-80. PubMed ID: 21448149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological characteristics of molecular subtypes of ulcerative colitis characterized by ferroptosis and neutrophil infiltration.
    Sun S; Mao Y; Le S; Zheng M; Li M; Chen Y; Chen J; Fan Y; Lv B
    Sci Rep; 2024 Apr; 14(1):9510. PubMed ID: 38664443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to Anti-α4β7 Blockade in Patients With Ulcerative Colitis Is Associated With Distinct Mucosal Gene Expression Profiles at Baseline.
    Gazouli M; Dovrolis N; Bourdakou MM; Gizis M; Kokkotis G; Kolios G; Michalopoulos G; Michopoulos S; Papaconstantinou I; Tzouvala M; Viazis N; Xourafas V; Zacharopoulou E; Zampeli E; Mantzaris G; Papatheodoridis G; Bamias G
    Inflamm Bowel Dis; 2022 Jan; 28(1):87-95. PubMed ID: 34042157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response.
    Haberman Y; Karns R; Dexheimer PJ; Schirmer M; Somekh J; Jurickova I; Braun T; Novak E; Bauman L; Collins MH; Mo A; Rosen MJ; Bonkowski E; Gotman N; Marquis A; Nistel M; Rufo PA; Baker SS; Sauer CG; Markowitz J; Pfefferkorn MD; Rosh JR; Boyle BM; Mack DR; Baldassano RN; Shah S; Leleiko NS; Heyman MB; Grifiths AM; Patel AS; Noe JD; Aronow BJ; Kugathasan S; Walters TD; Gibson G; Thomas SD; Mollen K; Shen-Orr S; Huttenhower C; Xavier RJ; Hyams JS; Denson LA
    Nat Commun; 2019 Jan; 10(1):38. PubMed ID: 30604764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
    Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
    Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy.
    Toedter G; Li K; Sague S; Ma K; Marano C; Macoritto M; Park J; Deehan R; Matthews A; Wu GD; Lewis JD; Arijs I; Rutgeerts P; Baribaud F
    Inflamm Bowel Dis; 2012 Aug; 18(8):1399-410. PubMed ID: 22223479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy.
    Dahlén R; Magnusson MK; Bajor A; Lasson A; Ung KA; Strid H; Öhman L
    Scand J Gastroenterol; 2015; 50(9):1118-26. PubMed ID: 25877762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
    Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
    J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
    Li K; Marano C; Zhang H; Yang F; Sandborn WJ; Sands BE; Feagan BG; Rubin DT; Peyrin-Biroulet L; Friedman JR; De Hertogh G
    Gastroenterology; 2020 Dec; 159(6):2052-2064. PubMed ID: 32853634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Diagnosis and Typological Characteristics Associated with Ferroptosis for Ulcerative Colitis
    Wang W; Song X; Ding S; Ma H
    Endocr Metab Immune Disord Drug Targets; 2024; 24(8):946-957. PubMed ID: 37957905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world Endoscopic and Histological Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative Colitis.
    Alsoud D; De Hertogh G; Compernolle G; Tops S; Sabino J; Ferrante M; Thomas D; Vermeire S; Verstockt B
    J Crohns Colitis; 2022 Nov; 16(10):1562-1570. PubMed ID: 35533353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis.
    Bjerrum JT; Hansen M; Olsen J; Nielsen OH
    Inflamm Bowel Dis; 2010 Jun; 16(6):999-1007. PubMed ID: 19834973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium.
    Koukos G; Polytarchou C; Kaplan JL; Oikonomopoulos A; Ziring D; Hommes DW; Wahed R; Kokkotou E; Pothoulakis C; Winter HS; Iliopoulos D
    Inflamm Bowel Dis; 2015 May; 21(5):996-1005. PubMed ID: 25738378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical review of ustekinumab for the treatment of active ulcerative colitis in adults.
    Vieujean S; Louis E; Danese S; Peyrin-Biroulet L
    Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):413-430. PubMed ID: 36949608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-interleukin-23 agents for the treatment of ulcerative colitis.
    Hanžel J; D'Haens GR
    Expert Opin Biol Ther; 2020 Apr; 20(4):399-406. PubMed ID: 31760827
    [No Abstract]   [Full Text] [Related]  

  • 36. Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling study.
    Dragasevic S; Stankovic B; Sokic-Milutinovic A; Milosavljevic T; Milovanovic T; Lukic S; Drazilov SS; Klaassen K; Kotur N; Pavlovic S; Popovic D
    Clin Immunol; 2018 Dec; 197():86-95. PubMed ID: 30193869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colonic MicroRNA Profiles, Identified by a Deep Learning Algorithm, That Predict Responses to Therapy of Patients With Acute Severe Ulcerative Colitis.
    Morilla I; Uzzan M; Laharie D; Cazals-Hatem D; Denost Q; Daniel F; Belleannee G; Bouhnik Y; Wainrib G; Panis Y; Ogier-Denis E; Treton X
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):905-913. PubMed ID: 30223112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population Pharmacokinetics and Exposure-Response Modeling Analyses of Ustekinumab in Adults With Moderately to Severely Active Ulcerative Colitis.
    Xu Y; Hu C; Chen Y; Miao X; Adedokun OJ; Xu Z; Sharma A; Zhou H
    J Clin Pharmacol; 2020 Jul; 60(7):889-902. PubMed ID: 32026499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of Tenascin C.
    Magnusson MK; Strid H; Isaksson S; Bajor A; Lasson A; Ung KA; Öhman L
    J Crohns Colitis; 2015 Jan; 9(1):56-65. PubMed ID: 25518051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.